The following shares are anticipated to remain in focus on Monday.
Maruti Suzuki India
Maruti sells zero items in home market in April New Delhi: The nation’s largest carmaker Maruti Suzuki India (MSI) on Friday mentioned it didn’t promote a single unit in the home market final month due to coronavirus-led nationwide lockdown.
Glenmark Pharma will get DCGI nod for scientific trials of Favipiravir tablets on COVID-19 sufferers New Delhi:Glenmark Pharmaceuticals on Thursday mentioned it has turn into the primary firm in India to obtain approval from Drug Controller General of India (DCGI) to conduct scientific trials of Favipiravir antiviral tablets for the therapy of COVID-19 sufferers.
FMCG main Hindustan Unilever on Thursday reported a decline of three.93 per cent in consolidated revenue to Rs 1,512 crore for the fourth quarter, impacted by the coronavirus disaster from mid-March.
SBI, ICICI Bank, Axis Bank
Fitch Ratings on Thursday downgraded the viability scores (VR) of State Bank of India (SBI), ICICI Bank and Axis Bank to ‘bb’ from ‘bb+’ on account of deteriorating working setting for banks amid the COVID-19 pandemic. The world ranking company additionally downgraded Bank of Baroda’s (BOB) VR by one notch to ‘bb-‘, from ‘bb’. The company affirmed the long-term issuer default scores (IDR) of SBI and BOB at ‘BBB-‘ and people of ICICI Bank and Axis Bank at ‘BB+’.
With PTI Inputs